###begin article-title 0
###xml 17 24 17 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC10A2</italic>
A Variant of the SLC10A2 Gene Encoding the Apical Sodium-Dependent Bile Acid Transporter Is a Risk Factor for Gallstone Disease
###end article-title 0
###begin p 1
Conceived and designed the experiments: OR SH. Performed the experiments: OR. Analyzed the data: OR. Wrote the paper: OR SH. Principal head and leading investigator of this project: EFS. Designed and monitored the genotyping assays: ES MS. Analyzed the statistical data: SW. Conceived and designed the measurements in the Aachen population: MK JR HW FL.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 226 233 226 233 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC10A2</italic>
###xml 300 307 300 307 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC10A2</italic>
Cholelithiasis is a multifactorial process and several mechanisms of gallstone formation have been postulated. As one of these mechanisms, a decreased expression of the ileal apical sodium-dependent bile acid transporter gene SLC10A2 in gallstone carriers was described previously. In this study the SLC10A2 gene was investigated to identify novel genetic variants and their association with gallstone formation.
###end p 3
###begin title 4
Methodology/Principal Findings
###end title 4
###begin p 5
###xml 274 281 274 281 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC10A2</italic>
###xml 587 594 587 594 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC10A2</italic>
###xml 720 729 720 729 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs9514089</italic>
###xml 787 788 787 788 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 878 887 878 887 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs9514089</italic>
###xml 974 975 974 975 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1037 1046 1037 1046 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs9514089</italic>
###xml 1098 1099 1098 1099 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1224 1225 1224 1225 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1284 1285 1284 1285 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1352 1353 1352 1353 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1411 1420 1411 1420 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs9514089</italic>
###xml 1515 1516 1515 1516 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 921 929 <span type="species:ncbi:9606">patients</span>
###xml 1342 1350 <span type="species:ncbi:9606">patients</span>
Study subjects were selected with the presence or absence of gallstones confirmed by ultrasound and medical history. Genomic DNA was obtained from blood leukocytes. Sequence analysis was performed of all six exonic and flanking regions as well as of 2,400 base pairs of the SLC10A2 promoter in a cohort of gallstone carriers and control subjects from Stuttgart, Germany. Genotype frequencies of newly identified genetic variants (n = 6) and known single nucleotide polymorphisms (n = 24) were established using MALDI-TOF mass spectrometry. Six new genetic variants were found within the SLC10A2 gene. Although none of the variants was linked to gallstone disease in the Stuttgart cohort overall, the minor allele of SNP rs9514089 was more prevalent in male non-obese gallstone carriers (p = 0.06680, OR = 11.00). In a separate population from Aachen, Germany, the occurrence of rs9514089 was two-fold higher in gallstone patients (22%) than in corresponding controls (11%) (p = 0.00995, OR = 2.19). In the pooled Aachen/Stuttgart cohort rs9514089 was highly significantly linked to cholelithiasis (p = 0.00767, OR = 2.04). A more frequent occurrence was observed for male gallstone carriers (22%) compared to controls (9%) (p = 0.01017, OR = 2.99), for the total normal weight group (p = 0.00754, OR = 2.90), and for male non-obese gallstone patients (p = 0.01410, OR = 6.85). Moreover, for the minor allele of rs9514089 an association with low plasma cholesterol levels was found especially in gallstone carriers (p = 0.05).
###end p 5
###begin title 6
Conclusions/Significance
###end title 6
###begin p 7
###xml 19 26 19 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC10A2</italic>
###xml 153 162 153 162 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs9514089</italic>
###xml 257 266 257 266 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs9514089</italic>
###xml 80 86 <span type="species:ncbi:9606">humans</span>
We have identified SLC10A2 as a novel susceptibility gene for cholelithiasis in humans. Comprehensive statistical analysis provides strong evidence that rs9514089 is a genetic determinant especially in male non-obese gallstone carriers. The minor allele of rs9514089 is related to differences in plasma cholesterol levels among the subjects.
###end p 7
###begin title 8
Introduction
###end title 8
###begin p 9
###xml 103 106 103 106 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007321-Everhart1">[1]</xref>
###xml 107 110 107 110 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007321-Poupon1">[4]</xref>
###xml 342 345 342 345 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007321-Katsika1">[5]</xref>
###xml 346 349 346 349 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007321-Wittenburg1">[7]</xref>
###xml 139 145 <span type="species:ncbi:9606">humans</span>
###xml 164 168 <span type="species:ncbi:10090">mice</span>
Cholelithiasis is the most common gastrointestinal disease with a prevalence of 15% in European adults [1]-[4]. Family and twin studies in humans as well as inbred mice have clearly demonstrated that a complex genetic basis determines the individual risk to develop cholesterol gallstones in addition to factors such as obesity and pregnancy [5]-[7].
###end p 9
###begin p 10
###xml 100 103 100 103 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007321-Wittenburg2">[8]</xref>
###xml 105 108 105 108 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007321-Wittenburg3">[9]</xref>
###xml 249 252 249 252 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007321-Puppala1">[6]</xref>
###xml 271 275 271 275 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007321-Rosmorduc1">[10]</xref>
###xml 327 332 327 332 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABCB4</italic>
###xml 573 578 573 578 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Abcb4</italic>
###xml 593 597 593 597 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007321-Lammert1">[11]</xref>
###xml 662 667 662 667 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABCG8</italic>
###xml 755 759 755 759 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007321-Buch1">[12]</xref>
###xml 869 873 869 873 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007321-Grnhage1">[13]</xref>
###xml 893 900 893 900 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s2">results</xref>
###xml 968 976 968 976 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABCG5/G8</italic>
###xml 1017 1020 1017 1020 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007321-Wittenburg3">[9]</xref>
###xml 1070 1072 1070 1072 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">64</sup>
###xml 1092 1093 1089 1090 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 1115 1120 1112 1117 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ADRB3</italic>
###xml 1160 1164 1157 1161 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007321-Klass1">[14]</xref>
###xml 1382 1386 1379 1383 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007321-Kovacs1">[15]</xref>
###xml 87 93 <span type="species:ncbi:10090">murine</span>
###xml 135 140 <span type="species:ncbi:9606">human</span>
###xml 474 482 <span type="species:ncbi:9606">patients</span>
###xml 502 508 <span type="species:ncbi:9606">humans</span>
###xml 588 592 <span type="species:ncbi:10090">mice</span>
###xml 630 636 <span type="species:ncbi:9606">humans</span>
###xml 1151 1159 <span type="species:ncbi:9606">patients</span>
###xml 1256 1261 <span type="species:ncbi:10090">mouse</span>
Several chromosomal regions exhibit linkage to gallstone disease. Complementary to the murine model [8], [9], the detailed analysis of human gallstone susceptibility genes in Mexican families provided suggestive evidence of linkage on chromosome 1p [6]. Rosmorduc et al. [10] showed that rare loss of function mutations in the ABCB4 gene encoding the hepatocanalicular transporter required for biliary phospatidylcholine secretion may lead to gallstone formation in certain patients. These findings in humans are consistent with the spontaneous occurrence of gallstones in Abcb4 knockout mice [11]. An increased gallstone risk in humans was demonstrated for the ABCG8 19H allele by a genomewide association scan with 500,000 SNPs in Caucasian individuals [12]. These findings were also confirmed in the combined linkage and association study by Grunhage and co-workers [13]. Additionally, the results are consistent with supporting evidence from animal model that the ABCG5/G8 transporter is a lithogenic risk factor [9]. Another recent association study observed an Arg64-variant of the beta3-adrenergic receptor (ADRB3) more frequently in gallstone patients [14]. Moreover, variations of the gene encoding the nuclear bile salt receptor FXR in an inbred mouse model and in three ethnically distinct populations were described as risk factors for the development of cholelithiasis [15].
###end p 10
###begin p 11
###xml 150 157 150 157 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC10A2</italic>
###xml 426 430 419 423 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007321-Bergheim1">[16]</xref>
###xml 432 436 425 429 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007321-Renner1">[17]</xref>
###xml 516 520 509 513 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007321-Klass2">[18]</xref>
###xml 631 635 624 628 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007321-Bergheim1">[16]</xref>
###xml 769 773 762 766 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007321-Holzer1">[19]</xref>
###xml 874 878 867 871 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007321-KullakUblick1">[20]</xref>
###xml 986 990 979 983 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007321-Hofmann1">[21]</xref>
###xml 1210 1214 1203 1207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007321-Dowling1">[22]</xref>
###xml 1423 1427 1416 1420 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007321-Berr1">[23]</xref>
###xml 1428 1432 1421 1425 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007321-Zanlungo2">[27]</xref>
###xml 225 233 <span type="species:ncbi:9606">patients</span>
###xml 760 768 <span type="species:ncbi:9606">patients</span>
###xml 1173 1181 <span type="species:ncbi:9606">patients</span>
In the current study we follow up on our previous work that investigated a role of the apical sodium-dependent bile acid transporter (ASBT, gene name SLC10A2) in gallstone formation. We have shown that in non-obese gallstone patients, ASBT expression is diminished, and that it is associated with low cytosolic ileal lipid binding protein (ILBP) and basolateral organic solute bile acid exporter (OSTalpha-OSTbeta) expression [16], [17]. In line with differences in cholesterol metabolism in lean and obese subjects [18], the reduced expression of the transporter was weight-specific and observed in normal weight individuals only [16]. Furthermore, subclinical inflammation was excluded as the molecular pathomechanism of reduced ASBT expression in gallstone patients [19]. The role of this transporter has been suggested to be the major determinant of bile acid pool size [20]. The size of the circulating pool of bile acids is an essential factor influencing cholesterol homeostasis [21]. Moreover, an impaired intestinal bile acid absorption, resulting in fecal bile acid loss and a decreased bile acid pool size, was identified to represent the primary defect in some patients with cholesterol gallstones [22]. Accordingly, a reduction of the bile acid pool size and the cholesterol supersaturation of gallbladder bile were identified as pivotal pathophysiological defects that promote cholesterol gallstone formation [23]-[27].
###end p 11
###begin p 12
###xml 62 69 62 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC10A2</italic>
###xml 184 191 184 191 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC10A2</italic>
###xml 255 259 255 259 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007321-Wong1">[28]</xref>
###xml 326 333 326 333 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC10A2</italic>
###xml 460 464 460 464 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007321-Oelkers1">[29]</xref>
###xml 483 490 483 490 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC10A2</italic>
###xml 584 588 584 588 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007321-Johnson1">[30]</xref>
###xml 632 639 632 639 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC10A2</italic>
###xml 779 783 779 783 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007321-Love1">[31]</xref>
###xml 998 1002 998 1002 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007321-Duane1">[32]</xref>
###xml 1099 1106 1099 1106 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC10A2</italic>
###xml 1142 1146 1142 1146 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007321-Renner2">[33]</xref>
###xml 159 164 <span type="species:ncbi:9606">human</span>
###xml 226 233 <span type="species:ncbi:9606">patient</span>
###xml 320 325 <span type="species:ncbi:9606">human</span>
###xml 729 736 <span type="species:ncbi:9606">patient</span>
###xml 881 889 <span type="species:ncbi:9606">patients</span>
Based on these findings we hypothesized that mutations of the SLC10A2 gene might result in gallstone formation by impairing the bile acid pool size. The first human mutation rendering SLC10A2 dysfunctional was identified in a patient with Crohn's disease [28]. Moreover, it was shown that inherited mutations within the human SLC10A2 gene are responsible for the abolished bile acid transport in a family with congenital primary bile acid malabsorption (PBAM) [29]. In addition, the SLC10A2 region was suggested to be relevant in bilirubin metabolism in a genome wide screening study [30]. Also, the frame-shift mutation 646insG in SLC10A2, which was associated with the abolished bile acid transport activity, was detected in a patient with familial hypertriglyceridemia (FHTG) [31]. In addition to genetic investigations, impaired intestinal bile acid absorption was observed in patients with hypertriglyceridemia as a result of diminished expression of apical bile acid transporter protein ASBT [32]. Recently, we demonstrated a reduced expression of ASBT that was linked to a haplotype block of SLC10A2 containing a total of ten variants [33].
###end p 12
###begin p 13
###xml 63 70 63 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC10A2</italic>
###xml 276 283 276 283 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC10A2</italic>
###xml 379 388 379 388 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs9514089</italic>
###xml 509 516 509 516 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC10A2</italic>
###xml 444 449 <span type="species:ncbi:9606">human</span>
The aim of the present study was to systematically analyze the SLC10A2 gene for genetic variants and to investigate whether the variants are associated with the development of gallstones. We established the genotype frequencies of a total of 30 sequence variations within the SLC10A2 gene; six of these variants were newly identified. Most importantly, an association of the SNP rs9514089 with gallstone prevalence was observed in two distinct human Caucasian populations suggesting that a genetic variant of SLC10A2 confers an increased risk of gallstone formation.
###end p 13
###begin title 14
Results
###end title 14
###begin title 15
###xml 21 28 21 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC10A2</italic>
Sequence Analysis of SLC10A2
###end title 15
###begin p 16
###xml 71 78 71 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC10A2</italic>
###xml 374 381 374 381 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC10A2</italic>
###xml 681 688 681 688 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007321-t001">Table 1</xref>
To identify novel genetic variants associated with cholelithiasis, the SLC10A2 gene was screened by sequencing, using a total of 93 samples from the Stuttgart population. The mutational analysis of 60 gallstone carriers and 33 control individuals resulted in the identification of six novel distinct variants in the untranslated region (5'-UTR) and in the coding regions of SLC10A2. These genetic variants (two in the 5' UTR region, two in exon 1 and two in exon 5) were found in female and in male gallstone carriers as well as in one male control. All individuals carried the newly identified variants in the heterozygous state. Detailed information of the variants is listed in Table 1.
###end p 16
###begin title 17
Main characteristics of all 30 SNPs examined in the Stuttgart population.
###end title 17
###begin p 18
###xml 80 87 80 87 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC10A2</italic>
SNPs are numbered 1-30 reflecting their sequential order on the physical map of SLC10A2 sequence.
###end p 18
###begin p 19
5'-UTR = untranslated region.
###end p 19
###begin p 20
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</sup>
###xml 0 1 0 1 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>a</sup></bold>
aNumbering according to transcript NM_00452 including the transition initiation codon.
###end p 20
###begin p 21
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</sup>
###xml 0 1 0 1 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>b</sup></bold>
bNumbering according to NP_00443.1 starting at translation initiation codon.
###end p 21
###begin p 22
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</sup>
###xml 0 1 0 1 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>c</sup></bold>
cMinor allele frequencies (MAF) are indicated in bold.
###end p 22
###begin p 23
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sup>
###xml 0 1 0 1 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>d</sup></bold>
dHardy-Weinberg equilibrium.
###end p 23
###begin p 24
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">e</sup>
###xml 0 1 0 1 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>e</sup></bold>
###xml 69 76 69 76 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC10A2</italic>
###xml 88 92 88 92 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007321-Duane1">[32]</xref>
ePolymorphism was previously described to be associated with reduced SLC10A2-expression [32].
###end p 24
###begin p 25
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">f</sup>
###xml 0 1 0 1 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>f</sup></bold>
fNewly identified genetic variant.
###end p 25
###begin p 26
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</sup>
###xml 0 1 0 1 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>g</sup></bold>
grs-number is available with the next dbSNP Build, B131 (planned for November 2009).
###end p 26
###begin title 27
###xml 22 29 22 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC10A2</italic>
Genetic Variations of SLC10A2 in the Stuttgart Cohort
###end title 27
###begin p 28
###xml 332 339 332 339 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC10A2</italic>
###xml 523 530 523 530 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007321-t001">Table 1</xref>
###xml 1295 1302 1295 1302 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC10A2</italic>
To investigate whether any of the variants were associated with gallstones, we compared the genotype frequencies of all single nucleotide polymorphisms (SNPs) in gallstone carriers and control subjects in the Stuttgart cohort. In addition to the newly identified genetic variants, based on frequency, 24 previously reported SNPs of SLC10A2 were selected from the NCBI data bases () to explore their association with cholelithiasis. The main characteristics of all 30 SNPs examined in the Stuttgart population are listed in Table 1. The study population was subdivided into weight-, gender- and disease-specific subgroups and genotype frequencies, odds ratios (ORs) and confidence intervals (CI) for each subgroup were calculated to obtain genotype-associated disease risk estimations. Moreover, the dominant and recessive models of inheritance were tested by analyzing wild type homozygous individuals (MM) versus all carriers of the minor variant (mm) or by comparison of wild type homozygous and heterozygous (Mm) individuals to the subjects with the minor allele ((MM+Mm)< >mm). Generally, in a total of 127 genotyped individuals the frequencies of most common SNPs showed neither significant gender-specific nor weight-specific differences. The overall minor allele frequencies (MAF) of the SLC10A2 SNPs ranged from 0 to 0.366. The majority of these SNPs displayed MAF lower than 10% in the population analyzed.
###end p 28
###begin p 29
###xml 66 75 66 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs3759501</italic>
###xml 77 86 77 86 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs3759502</italic>
###xml 88 97 88 97 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs3759503</italic>
###xml 99 108 99 108 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs3759504</italic>
###xml 110 119 110 119 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs7990819</italic>
###xml 121 131 121 131 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs16961281</italic>
###xml 133 143 133 143 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs41281682</italic>
###xml 311 321 311 321 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs71653645</italic>
###xml 336 346 336 346 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs71653646</italic>
###xml 481 491 481 491 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs71640246</italic>
###xml 685 695 685 695 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs71640247</italic>
###xml 906 915 906 915 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs1329516</italic>
###xml 925 933 925 933 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs157381</italic>
###xml 957 967 957 967 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs72547505</italic>
###xml 1106 1116 1106 1116 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs41281680</italic>
###xml 1124 1134 1124 1134 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs55971546</italic>
###xml 1140 1150 1140 1150 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs60380298</italic>
###xml 1159 1168 1159 1168 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">s41281678</italic>
###xml 1175 1183 1175 1183 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs188096</italic>
###xml 1210 1222 1210 1222 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(rs56398830)</italic>
###xml 1233 1240 1233 1240 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC10A2</italic>
###xml 1331 1335 1331 1335 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007321-Wong1">[28]</xref>
###xml 1440 1441 1440 1441 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1582 1583 1582 1583 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1292 1299 <span type="species:ncbi:9606">patient</span>
The polymorphisms of the promoter and untranslated regions (UTR) (rs3759501, rs3759502, rs3759503, rs3759504, rs7990819, rs16961281, rs41281682) were detected in gallstone carriers and controls, and their distributions did not exhibit any significant differences between both groups. The novel genetic variants rs71653645/c.-548C>T and rs71653646/c.-332C>T, that were identified in two separate gallstone carriers, were not found in any additional subjects. The synonymous variant rs71640246/p.N52 in exon 1 was identified in two male gallstone carriers only. Moreover, the female gallstone carrier with the nucleotide change G-to-A leading to the premature stop codon at position 66 (rs71640247/p.W66X) represented a single case of individual sequence alteration. Notably, in our cohort no variant alleles were found for the following four sequence variants that were described in the database: intron 1: rs1329516, exon 2: rs157381/Pro142, exon 5: L243P, rs72547505/T262M. In addition, there were no statistical differences between gallstone carriers and controls for the various coding region variants: rs41281680/p.A43, rs55971546/A98I rs60380298/V159I, rs41281678/L169, rs188096/A171S. The mutation P290S (rs56398830) rendering SLC10A2 dysfunctional, which was identified initially in a patient diagnosed with Crohn's disease [28], was present at higher frequency in the control population (5.2%) compared to gallstone carriers (2.6%, p = 0.3534, OR = 0.6393). Moreover, this SNP occurred more frequently in overweight individuals (6.9%) compared to non-obese subjects (1.7%) (p = 0.0638, OR = 3.082). Furthermore, the newly identified sequence alteration p.F296L was only present in the control group with a frequency of 1.4%. On the other hand, the distribution of the variant p.F304L was similar between the case (1.8%) and control (1.4%) groups.
###end p 29
###begin p 30
###xml 49 58 49 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs9514089</italic>
###xml 322 330 322 330 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007321.s001">Table S1</xref>
Interestingly, for one of the sequence variants, rs9514089, we observed a trend towards an association with cholelithiasis in this Stuttgart population. However, this association was observed only in male gallstone carriers with normal weight (20%) compared to male normal weight controls (0%) (data shown as supplemental Table S1).
###end p 30
###begin title 31
###xml 0 7 0 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC10A2</italic>
###xml 21 30 21 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs9514089</italic>
SLC10A2 Polymorphism rs9514089 in the Aachen Cohort
###end title 31
###begin p 32
###xml 34 43 34 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs9514089</italic>
###xml 272 281 272 281 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs9514089</italic>
###xml 465 466 465 466 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 727 728 727 728 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 799 800 799 800 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 851 859 851 859 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007321.s002">Table S2</xref>
###xml 866 868 866 868 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p-</italic>
###xml 789 797 <span type="species:ncbi:9606">patients</span>
To confirm the association of the rs9514089 polymorphism to gallstones, a larger additional population from Aachen, comprising matched pairs of gallstone carriers and controls, was analyzed. Interestingly, the Aachen cohort expressed a clearly higher SNP frequency of the rs9514089 variant in gallstone carriers of the total population as well as in every distinct subgroup compared with control subjects. In the total population, this association was significant (p = 0.00995, OR = 2.19). In this population, the G allele was more frequent in gallstone carriers (22%) compared to controls (11%). Moreover, the significant association of the minor allele with gallstone prevalence was also observed in male gallstone carriers (p = 0.03319, OR = 2.79) as well as in normal weight gallstone patients (p = 0.03517, OR = 2.59) (data shown as supplemental Table S2). The p-values and risk estimations for the Aachen cohort and the pooled population are listed for the recessive model.
###end p 32
###begin title 33
###xml 0 7 0 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC10A2</italic>
###xml 21 30 21 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs9514089</italic>
SLC10A2 Polymorphism rs9514089 in the Pooled Population
###end title 33
###begin p 34
###xml 139 148 139 148 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs9514089</italic>
###xml 219 226 219 226 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007321-t002">Table 2</xref>
###xml 288 297 288 297 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs9514089</italic>
###xml 329 330 329 330 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 732 733 732 733 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1029 1030 1029 1030 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1242 1243 1242 1243 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 516 524 <span type="species:ncbi:9606">patients</span>
###xml 1182 1190 <span type="species:ncbi:9606">patients</span>
To increase the power of our analysis, the populations of Stuttgart and Aachen were pooled. For this analysis, the distribution of the SNP rs9514089 was determined in a total of 255 controls and 240 gallstone carriers (Table 2). In the entire pooled cohort, we observed an association of rs9514089 with gallstone carrier status (p = 0.00767, OR = 2.04). The increased frequency of the homozygous GG genotype in the combined analysis of all samples from both independent German cohorts was observed for all gallstone patients (GG frequency 20%) in comparison to the control group (GG frequency 11%). In accordance with our results in the individual single cohorts, the pooled population also demonstrated a more frequent occurrence (p = 0.01017, OR = 2.99) of the genetic variant in male gallstone carriers (22%) compared to male controls (9%). Furthermore, the analysis of the different gallstone carrier subgroups revealed a significant association of the minor variant with gallstone susceptibility in the normal weight group (p = 0.00754, OR = 2.90). In contrast to female normal weight gallstone carriers, an increased SNP frequency was observed in the male non-obese gallstone patients in comparison to the male non-obese control group (p = 0.01410, OR = 6.85).
###end p 34
###begin title 35
###xml 29 38 29 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs9514089</italic>
Prevalence of gallstones and rs9514089 polymorphism in the pooled Stuttgart and Aachen cohorts.
###end title 35
###begin p 36
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
p<0.05 was regarded as statistically significant, odds ratio (OR) and 95% confidence interval (CI).
###end p 36
###begin p 37
AA = major allele.
###end p 37
###begin p 38
Ag = heterozygote allele.
###end p 38
###begin p 39
###xml 96 97 94 95 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 100 101 98 99 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">e</sup>
###xml 100 101 98 99 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>e</sup></bold>
###xml 131 132 129 130 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 135 136 133 134 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">f</sup>
###xml 135 136 133 134 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>f</sup></bold>
gg = minor allele, the subjects were divided into subgroups with body mass index (BMI)</=25 kg/m2 = e normal weight and BMI>25 kg/m2 = f overweight.
###end p 39
###begin title 40
###xml 0 9 0 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs9514089</italic>
###xml 37 44 37 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC10A2</italic>
rs9514089 GG Genotype Frequencies in SLC10A2 and Plasma Lipid Levels
###end title 40
###begin p 41
###xml 18 30 18 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">of rs9514089</italic>
###xml 200 208 200 208 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007321.s003">Table S3</xref>
###xml 421 430 421 430 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs9514089</italic>
###xml 570 579 570 579 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs9514089</italic>
###xml 644 645 644 645 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 927 936 927 936 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs9514089</italic>
###xml 1089 1090 1089 1090 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 387 395 <span type="species:ncbi:9606">patients</span>
###xml 484 492 <span type="species:ncbi:9606">patients</span>
###xml 782 790 <span type="species:ncbi:9606">patients</span>
###xml 817 825 <span type="species:ncbi:9606">patients</span>
The distributions of rs9514089 GG genotypes in both Stuttgart and Aachen populations as well as in the pooled group were analyzed with respect to age, BMI, plasma cholesterol and triglyceride levels (Table S3). For the pooled group, a correction term for the study centre was incorporated in the models. The various genotypes were not associated with age, BMI or triglycerides. However, patients carrying the G allele of rs9514089 displayed lower total cholesterol levels compared to patients with the A allele. In the association analysis, a significant association of rs9514089 and total cholesterol levels was observed in the Aachen cohort (p = 0.04, data not shown). The Stuttgart cohort demonstrated a non-significant trend towards lower cholesterol plasma levels in gallstone patients with GG genotypes than in patients with the major allele. In the pooled population, we confirmed the association of the GG genotypes of rs9514089 in gallstone carriers with low cholesterol levels. After correction by study centre, this association was only observed to display a borderline effect (p = 0.05).
###end p 41
###begin title 42
Discussion
###end title 42
###begin p 43
###xml 33 40 33 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SCL10A2</italic>
###xml 224 233 224 233 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs9514089</italic>
In this candidate gene study the SCL10A2 gene was systematically sequenced, and a first cohort from Stuttgart was genotyped for the association of a total of 30 SNPs with cholelithiasis. Among the analyzed variants, the SNP rs9514089 was significantly more prevalent in male non-obese gallstone carriers. Subsequently, this association was verified in an additional larger replication cohort. In addition this SNP was associated with lower plasma cholesterol values.
###end p 43
###begin p 44
###xml 201 206 201 206 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABCB4</italic>
###xml 255 259 255 259 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007321-Rosmorduc1">[10]</xref>
###xml 261 265 261 265 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007321-Nakken1">[34]</xref>
###xml 339 344 339 344 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Abcb4</italic>
###xml 359 363 359 363 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007321-Lammert1">[11]</xref>
###xml 437 442 437 442 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABCG8</italic>
###xml 525 529 525 529 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007321-Buch1">[12]</xref>
###xml 706 710 706 710 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007321-Grnhage1">[13]</xref>
###xml 875 879 872 876 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007321-Klass1">[14]</xref>
###xml 984 988 981 985 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007321-Kovacs1">[15]</xref>
###xml 1281 1288 1278 1285 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NR1H4_1</italic>
###xml 1303 1304 1300 1301 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 354 358 <span type="species:ncbi:10090">mice</span>
###xml 977 983 <span type="species:ncbi:9606">humans</span>
This is the first positive genetic association study of a factor involved in bile acid transport. Previous association studies have reported a linkage of gallstone formation and point mutations in the ABCB4 gene encoding the phospholipid transporter MDR3 [10], [34]. This is consistent with the spontaneous occurrence of cholelithiasis in Abcb4 knockout mice [11]. A genomewide association scan has linked the coding variant D19H of the ABCG8, the hepatocanalicular cholesterol transporter, to this disease with an OR of 2.2 [12]. This association was confirmed by Grunhage et al. in a nonparametric linkage analysis of affected sib pairs with the 19H allele compared to gallstone-free controls (OR = 3.0) [13]. The study of Klass et al. identified a gallstone-associated polymorphism in the hepatic beta3-adrenergic receptor (ADRB3) suggested to affect gallbladder motility [14]. Kovacs et al. described a linkage of variations of the FXR gene and gallstone susceptibility in humans [15]. Notably, the linkage to cholelithiasis was gender-specific (males: OR = 3.09; females: OR = 0.85). No association of this haplotype with gallstone prevalence could be found in a German cohort (OR = 0.83) and, in a Chilean female population a paradoxical trend towards a protective effect of NR1H4_1 was observed (p = 0.08, OR = 0.69).
###end p 44
###begin p 45
###xml 107 114 107 114 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC10A2</italic>
###xml 310 314 310 314 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007321-Wong1">[28]</xref>
###xml 316 320 316 320 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007321-Love1">[31]</xref>
###xml 322 326 322 326 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007321-Montagnani1">[35]</xref>
###xml 328 332 328 332 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007321-Montagnani2">[36]</xref>
###xml 488 497 488 497 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs9514089</italic>
###xml 501 508 501 508 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC10A2</italic>
###xml 698 707 698 707 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs9514089</italic>
###xml 732 733 732 733 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 804 813 804 813 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs9514089</italic>
###xml 1093 1094 1093 1094 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1156 1165 1156 1165 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs9514089</italic>
###xml 181 189 <span type="species:ncbi:9606">patients</span>
###xml 253 261 <span type="species:ncbi:9606">patients</span>
So far no gallstone-associated SNP has been described for bile acid transporters in the intestine. For the SLC10A2 gene only a few dysfunctional mutations were identified in single patients diagnosed with Crohn's disease, hypertriglyceridemia and/or in patients with different forms of bile acid malabsorption [28], [31], [35], [36]. However, these loss-of-function-mutations could not be associated with specific diseases in general. In the current study, we identified the polymorphism rs9514089 of SLC10A2 as the first intestinal bile acid related candidate for the development of gallstones. In the pooled cohort from Stuttgart and Aachen we found a significant association of the polymorphism rs9514089 with gallstone disease (p = 0.00767, OR = 2.04). In addition, we analyzed the effect of the SNP rs9514089 in different gender- and weight-specific groups. Herein, this sequence variant was significantly associated with cholelithiasis in the total male and in the total normal weight subgroups. However, the most significant linkage was found for male normal weight gallstone carriers (p = 0.01410, OR = 6.85), indicating that the occurrence of the rs9514089 polymorphism is gender- and weight-specific.
###end p 45
###begin p 46
###xml 114 121 114 121 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC10A2</italic>
###xml 446 455 446 455 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs9514089</italic>
###xml 664 671 664 671 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC10A2</italic>
###xml 1083 1087 1083 1087 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007321-Bergheim1">[16]</xref>
###xml 1074 1082 <span type="species:ncbi:9606">patients</span>
###xml 1118 1126 <span type="species:ncbi:9606">patients</span>
Although our study demonstrates, that the genetic gallstone disease risk is attributable to the GG variant in the SLC10A2 gene, it remains unclear how this genetic variant affects the function of the ASBT transporter and how these functional differences lead to gallstone disease. Several scenarios may possibly explain the different prevalence of this polymorphism in gallstone carriers and controls: First, in carriers of the G allele, the SNP rs9514089 could be the relevant polymorphism, causing a decreased transcription of the gene that could lead to a diminished epithelial bile acid uptake. Second, it may be hypothesized that the genomic structure of the SLC10A2 gene with the G allele is the major determinant of the diminished ASBT expression though post-transcriptional mechanisms could influence protein expression. Third, the GG variant could alter the binding of several transcription factors promoting gallstone formation. As mentioned above, we have previously shown that expression of this transporter is diminished in the ileum of normal weight gallstone patients [16]. Unfortunately, our cohort of patients from which we were able to obtain ileal biopsies is too small for genetic association studies.
###end p 46
###begin p 47
###xml 68 75 68 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC10A2</italic>
###xml 194 203 194 203 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs9514089</italic>
###xml 475 484 475 484 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs9514089</italic>
###xml 739 740 739 740 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 862 867 862 867 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABCG8</italic>
###xml 876 881 876 881 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABCG5</italic>
###xml 956 960 956 960 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007321-Berge1">[37]</xref>
###xml 961 965 961 965 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007321-Acalovschi1">[39]</xref>
###xml 1026 1031 1026 1031 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABCB4</italic>
###xml 1036 1042 1036 1042 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABCB11</italic>
###xml 1102 1106 1102 1106 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007321-Acalovschi2">[40]</xref>
###xml 1220 1224 1220 1224 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007321-Jiang1">[41]</xref>
###xml 1495 1504 1495 1504 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs9514089</italic>
###xml 1695 1699 1695 1699 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007321-Duane1">[32]</xref>
###xml 1730 1739 1730 1739 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs9514089</italic>
###xml 1547 1555 <span type="species:ncbi:9606">patients</span>
To assess whether the association results for the GG variant of the SLC10A2 gene were affected by confounding risk factors for gallstones, we performed a multivariate analysis that included the rs9514089 variant and lithogenic risk factors such as age, gender, BMI and plasma cholesterol levels. The only significant association relates to serum cholesterol in the Aachen population, where lower cholesterol levels, were found in gallstone carriers of the GG genotype of the rs9514089 variant compared with gallstone carriers with the major allele. Although this trend was confirmed in the Stuttgart cohort, in the pooled population the association of the GG genotype in gallstone carriers with low cholesterol levels was only borderline (p = 0.05). Such an association with a lipid transporter is in line with prior studies where the D19H and T400K variants of ABCG8 and the ABCG5 Q604E polymorphism were associated with altered plasma cholesterol levels [37]-[39]. On the other hand, Acalovschi et al. found no link between ABCB4 and ABCB11 polymorphisms, lithogenic dyslipidemia, and gallstone risk [40]. Furthermore, in previous studies low total cholesterol levels have been linked to the development of gallstones [41] but in our cohorts this was not the case. Therefore, and also because of the lack of significance in the total cohort, there is little evidence for a confounder effect of serum cholesterol in the present investigation. There was also no relevant association between the rs9514089 variant and triglyceride levels, although patients with hypertriglyceridemia have been demonstrated to exhibit diminished expression of apical sodium-dependent bile acid transporter protein [32]. To assess the association of rs9514089 polymorphism to plasma lipids further, future investigations in additional populations are required.
###end p 47
###begin p 48
###xml 29 36 29 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC10A2</italic>
###xml 118 125 118 125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s2">results</xref>
###xml 106 112 <span type="species:ncbi:9606">humans</span>
In conclusion, we identified SLC10A2 as a novel intestinal common susceptibility factor for gallstones in humans. The results of this study may prompt investigations which will address more comprehensive genotype-phenotype association. In the future, additional genetic risk factors are likely to be identified, which we envisage to provide novel means for the risk assessment and possibly prevention of gallstones.
###end p 48
###begin title 49
Materials and Methods
###end title 49
###begin title 50
Ethics statement
###end title 50
###begin p 51
The local ethics comittees (for the study population from Aachen: ethics committees from the Departement of Medicine University of Aachen and Departement of Medicine University of Leipzig as well as for the study population from Stuttgart: ethics committee of the University Hospital of Tuebingen and University Tuebingen) approved these studies and all subjects gave written informed consent prior to participation.
###end p 51
###begin title 52
NCBI data statement
###end title 52
###begin p 53
All new data have been deposited in GenBank (NCBI data bank ), rs-numbers are already available.
###end p 53
###begin title 54
Study populations and clinical characteristics
###end title 54
###begin p 55
###xml 232 236 232 236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007321-Bergheim1">[16]</xref>
###xml 238 242 238 242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007321-Renner1">[17]</xref>
###xml 244 248 244 248 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007321-Renner2">[33]</xref>
###xml 457 464 457 464 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007321-t003">Table 3</xref>
###xml 292 304 <span type="species:ncbi:9606">participants</span>
The study population from Stuttgart (Germany), comprises 127 individuals, of which 71 are healthy individuals and 56 are gallstone carriers. The recruitment criteria for the subjects included in this study were described previously [16], [17], [33]. The clinical characteristics of the study participants, including age, BMI, triglyceride and cholesterol levels did not differ significantly between the gallstone carriers and controls and are summarized in Table 3.
###end p 55
###begin title 56
###xml 34 46 <span type="species:ncbi:9606">participants</span>
Clinical characteristics of study participants from Stuttgart and Aachen cohorts.
###end title 56
###begin p 57
Values are given as means+/-SD; BMI = body mass index;
###end p 57
###begin p 58
 = normal range.
###end p 58
###begin p 59
###xml 81 85 81 85 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007321-Mella1">[42]</xref>
The characteristics of the Aachen population were, in part, published previously [42].
###end p 59
###begin p 60
###xml 201 205 201 205 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007321-Mella1">[42]</xref>
###xml 255 262 255 262 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007321-t003">Table 3</xref>
In the study population from Aachen (Germany), including 368 subjects with 184 matched pairs for age and BMI, the presence of gallstones was diagnosed by ultrasound or history of prior cholecystectomy [42]. Characteristics of the cohort are summarized in Table 3.
###end p 60
###begin p 61
The Caucasian origin of both cohorts was determined by name and personal interview.
###end p 61
###begin title 62
###xml 23 30 23 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC10A2</italic>
Mutational analysis of SLC10A2 gene
###end title 62
###begin p 63
###xml 141 148 141 148 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC10A2</italic>
###xml 1362 1366 1351 1355 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007321-denDunnen1">[43]</xref>
Based on the genomic sequence (Gene Bank Accession number: NC_000013.9), oligonucleotide primer sets were designed spanning all six exons of SLC10A2, the intron/exon junctions (50-100 nucleotides) as well as a 2,400 base pairs (bp) promoter fragment. Primers were created using Primer3 program (), the quality control was performed with Oligonucleotide Properties Calculator (), and the uniqueness in the genome was confirmed applying BLAST software (). For PCR reactions, the HotStarTaq (QIAGEN) and FastStart High Fidelity (Roche) DNA polymerase systems were used according to manufacturer's instructions. All PCR amplification reactions were performed on DYADtrade mark PCR thermal cyclers (MJ Research). PCR products were split into two different tubes to perform the forward and reverse amplifications. The sequencing PCR was performed using specific nested primers, according to standard procedures (Big Dye(R) Terminator Mix v 1.1, Applied Biosystems). DNA sequencing of both strands was performed by GENterprise Genomics (Mainz, Germany), followed by analysis on an ABI Prism 310 automated Genetic Analyzer (Applied Biosystems). Novel genetic variations were confirmed by repeated sequencing of PCR products in both directions. The nomenclature of the new variants follows the recommendations for the description of DNA changes by Dunnen and Antonarakis [43].
###end p 63
###begin title 64
Genotyping
###end title 64
###begin p 65
Analysis of SNPs was performed using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) of allele specific primer extension products. Genotype frequencies of the variants were established using two separate assays. All reactions, including PCR amplification, shrimp alkaline phosphatase treatment, and base extension were performed in 384-well plates (ABgene) with a Puredisk pipette robot (Cybio). PCR amplification and primer extension reaction were carried out in a DYADtrade mark PCR thermal cycler (MJ Research). For quality control we performed no-template controls in all plates and repeated analysis of 10% of randomly selected samples.
###end p 65
###begin p 66
###xml 51 60 51 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs9514089</italic>
In the study population from Aachen, genotyping of rs9514089 was performed using a TaqMan allelic discrimination assay (Custom TaqMan SNP Genotyping Assay; Applied Biosystems, Inc.). Oligonucleotide sequences of probes and PCR primers are available upon request. The TaqMan genotyping reaction was amplified (95degreesC for 10 min, and 92degreesC for 15 sec, and 60degreesC for 1 min, for 40 cycles) and fluorescence was detected on the ABI PRISM 7700 sequence detection system (Applied Biosystems, Inc.). To assess reproducibility, a random approximately5% selection of the sample was re-genotyped and all of these genotypes matched with genotypes initially designated.
###end p 66
###begin title 67
Multiplex reaction
###end title 67
###begin p 68
Five ng of genomic DNA were amplified by PCR, containing locus-specific primers and HotStarTaq DNA polymerase (QIAGEN). PCR conditions were 95degreesC for 15 minutes for hot start, followed by 44 cycles of denaturation at 95degreesC for 30 seconds, annealing at 56degreesC for 1 minute, extension at 72degreesC for 1 minute and finally incubation at 72degreesC for 10 minutes. Subsequently, PCR products were treated with shrimp alkaline phosphatase (iPLEXtrade mark Gold Kit, SEQUENOM) at 37degreesC for 20 minutes to remove excess of deoxynucleotide triphosphates, followed by 10 minutes at 85degreesC to inactivate the enzyme.
###end p 68
###begin title 69
Extension reactions
###end title 69
###begin p 70
Purified PCR products were used as templates for extension reactions with extension primers and iPLEX enzyme (iPLEXtrade mark Gold Kit, SEQUENOM) following the instructions of the supplier. The iPLEX reaction was performed using two-step 200 short cycles program (94degreesC, 30 seconds; 40 x (94degreesC, 5 seconds; 5 x (52degreesC, 5 seconds; 80degreesC, 5 seconds)); 72degreesC, 3 minutes). The final base extension products were treated with a cationic exchange resin to remove salts. Reaction solutions were dispensed onto the 384-well format SpectroCHIP(R) Array chips (SEQUENOM) and mass spectrometric analyses were performed on a Compact Mass Spectrometer. Data were analyzed using the Typer software (both SEQUENOM).
###end p 70
###begin p 71
Primer sequences for sequence analyses, multiplex reactions and extension reactions are available upon request.
###end p 71
###begin title 72
Computational methods and statistical analysis
###end title 72
###begin p 73
###xml 228 232 226 230 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007321-Wigginton1">[44]</xref>
###xml 290 292 288 290 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p-</italic>
###xml 613 622 611 620 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs9514089</italic>
###xml 739 743 737 741 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007321-Gonzalez1">[45]</xref>
###xml 855 864 853 862 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs9514089</italic>
###xml 1182 1184 1180 1182 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p-</italic>
###xml 34 46 <span type="species:ncbi:9606">participants</span>
Clinical characteristics of study participants are expressed as means +/- (SD). Observed and expected allele and genotype frequencies within the study population were compared by means of Hardy-Weinberg equilibrium calculations [44]. Data were considered in Hardy-Weinberg equilibrium when p-values were >0.05. Statistical analysis of differences between gallstone carriers and controls was done using Fisher's exact and Chi-square tests. Risk estimations for the development of gallstones were calculated as odds ratios (ORs) together with a 95% confidence interval (CI). Associations of clinical parameters and rs9514089 polymorphism, corrected for study centre (Aachen or Stuttgart), were analyzed with library SNPassoc (version 1.5-8) [45] of the statistical software R-2.8.1 (). Library SNPassoc was also applied in order to assess the effect of the rs9514089 polymorphism on the development of gallstones in multivariate models. Here, we accounted for the adjustment factors age, gender, body mass index (BMI) and plasma cholesterol levels. Moreover, for the pooled population, a correction term for the study centres was included. All statistical tests were two-tailed and a p-value of <0.05 was considered as statistically significant.
###end p 73
###begin title 74
Supporting Information
###end title 74
###begin p 75
###xml 325 326 323 324 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 360 361 358 359 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
Prevalence of gallstones and rs9514089 polymorphism in the Stuttgart cohort. p<0.05 was regarded as statistically significant, odds ratio (OR) and 95% confidence interval (CI), a AA = major allele, b Ag = heterozygous allele, c gg = minor allele, the subjects were divided into subgroups with body mass index, (BMI)</=25 kg/m2 = e normal weight and BMI>25 kg/m2 = f overweight.
###end p 75
###begin p 76
(0.04 MB DOC)
###end p 76
###begin p 77
Click here for additional data file.
###end p 77
###begin p 78
###xml 322 323 320 321 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 357 358 355 356 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
Prevalence of gallstones and rs9514089 polymorphism in the Aachen cohort. p<0.05 was regarded as statistically significant, odds ratio (OR) and 95% confidence interval (CI), a AA = major allele, b Ag = heterozygous allele, c gg = minor allele, the subjects were divided into subgroups with body mass index, (BMI)</=25 kg/m2 = e normal weight and BMI>25 kg/m2 = f overweight.
###end p 78
###begin p 79
(0.04 MB DOC)
###end p 79
###begin p 80
Click here for additional data file.
###end p 80
###begin p 81
Clinical parameters in pooled Stuttgart and Aachen controls and gallstone carriers with distinct rs9514089 genotypes. Values are given as means+/-SEM; BMI = body mass index; a = normal range; b = in the recessive model, corrected by study centre.
###end p 81
###begin p 82
(0.04 MB DOC)
###end p 82
###begin p 83
Click here for additional data file.
###end p 83
###begin p 84
###xml 100 108 <span type="species:ncbi:9606">patients</span>
We thank the staff of the gastroenterological departments and the endoscopy team for recruitment of patients. The authors also thank Dr. Christina Justenhoven for the helpful and competent discussion of this manuscript. The authors are also very grateful to Andre Strohmeyer and Silke Schimmel for their excellent technical assistance.
###end p 84
###begin title 85
References
###end title 85
###begin article-title 86
Prevalence and ethnic differences in gallbladder disease in the United States.
###end article-title 86
###begin article-title 87
The burden of selected digestive diseases in the United States.
###end article-title 87
###begin article-title 88
Cholesterol gallstone disease.
###end article-title 88
###begin article-title 89
Pathophysiology of biliary lithiasis.
###end article-title 89
###begin article-title 90
Genetic and environmental influences on symptomatic gallstone disease: a Swedish study of 43,141 twin pairs.
###end article-title 90
###begin article-title 91
A genomewide search finds major susceptibility loci for gallbladder disease on chromosome 1 in Mexican Americans.
###end article-title 91
###begin article-title 92
Genetic predisposition to gallbladder stones.
###end article-title 92
###begin article-title 93
###xml 68 72 <span type="species:ncbi:10090">mice</span>
Mapping cholesterol gallstone susceptibility (Lith) genes in inbred mice.
###end article-title 93
###begin article-title 94
###xml 112 116 <span type="species:ncbi:10090">mice</span>
FXR and ABCG5/ABCG8 as determinants of cholesterol gallstone formation from quantitative trait locus mapping in mice.
###end article-title 94
###begin article-title 95
ABCB4 gene mutation-associated cholelithiasis in adults.
###end article-title 95
###begin article-title 96
###xml 55 59 <span type="species:ncbi:10090">mice</span>
Spontaneous cholecysto- and hepatolithiasis in Mdr2-/- mice: a model for low phospholipid-associated cholelithiasis.
###end article-title 96
###begin article-title 97
###xml 115 120 <span type="species:ncbi:9606">human</span>
A genome-wide association scan identifies the hepatic cholesterol transporter ABCG8 as a susceptibility factor for human gallstone disease.
###end article-title 97
###begin article-title 98
###xml 28 34 <span type="species:ncbi:9606">humans</span>
Increased gallstone risk in humans conferred by common variant of hepatic ATP-binding cassette transporter for cholesterol.
###end article-title 98
###begin article-title 99
Arg64 variant of the beta3-adrenergic receptor is associated with gallstone formation.
###end article-title 99
###begin article-title 100
###xml 98 102 <span type="species:ncbi:10090">mice</span>
###xml 107 113 <span type="species:ncbi:9606">humans</span>
Variation of the gene encoding the nuclear bile salt receptor FXR and gallstone susceptibility in mice and humans.
###end article-title 100
###begin article-title 101
Apical sodium bile acid transporter and ileal lipid binding protein in gallstone carriers.
###end article-title 101
###begin article-title 102
Reduced ileal expression of OST{alpha}-OST{beta} in non-obese gallstone disease.
###end article-title 102
###begin article-title 103
Biliary lipids, cholesterol and bile synthesis: different adaptive mechanisms to dietary cholesterol in lean and obese subjects.
###end article-title 103
###begin article-title 104
Diminished expression of apical sodium-dependent bile acid transporter in gallstone disease is independent of ileal inflammation.
###end article-title 104
###begin article-title 105
Enterohepatic bile salt transporters in normal physiology and liver disease.
###end article-title 105
###begin article-title 106
Bile Acids: The Good, the Bad, and the Ugly.
###end article-title 106
###begin article-title 107
Review: pathogenesis of gallstones.
###end article-title 107
###begin article-title 108
Disorders of bile acid metabolism in cholesterol gallstone disease.
###end article-title 108
###begin article-title 109
###xml 75 83 <span type="species:ncbi:9606">Patients</span>
Effects of Dietary Cholesterol on Cholesterol and Bile Acid Homeostasis in Patients with Cholesterol Gallstones.
###end article-title 109
###begin article-title 110
Cholesterol gallstone formation. 2. Pathobiology and pathomechanics.
###end article-title 110
###begin article-title 111
The molecular and metabolic basis of biliary cholesterol secretion and gallstone disease.
###end article-title 111
###begin article-title 112
Hepatic cholesterol transport from plasma into bile: implications for gallstone disease.
###end article-title 112
###begin article-title 113
Identification of a mutation in the ileal sodium-dependent bile acid transporter gene that abolishes transport activity.
###end article-title 113
###begin article-title 114
Primary bile acid malabsorption caused by mutations in the ileal sodium-dependent bile acid transporter gene (SLC10A2).
###end article-title 114
###begin article-title 115
Genome-wide association meta-analysis for total serum bilirubin levels.
###end article-title 115
###begin article-title 116
Analysis of the ileal bile acid transporter gene, SLC10A2, in subjects with familial hypertriglyceridemia.
###end article-title 116
###begin article-title 117
###xml 117 125 <span type="species:ncbi:9606">patients</span>
Diminished gene expression of ileal apical sodium bile acid transporter explains impaired absorption of bile acid in patients with hypertriglyceridemia.
###end article-title 117
###begin article-title 118
Mutation screening of apical sodium-dependent bile acid transporter (SLC10A2): novel haplotype block including six newly identified variants linked to reduced expression.
###end article-title 118
###begin article-title 119
ABCB4 sequence variations in young adults with cholesterol gallstone disease.
###end article-title 119
###begin article-title 120
###xml 80 88 <span type="species:ncbi:9606">patients</span>
Absence of dysfunctional ileal sodium-bile acid cotransporter gene mutations in patients with adult-onset idiopathic bile acid malabsorption.
###end article-title 120
###begin article-title 121
Analysis of ileal sodium/bile acid cotransporter and related nuclear receptor genes in a family with multiple cases of idiopathic bile acid malabsorption.
###end article-title 121
###begin article-title 122
Heritability of plasma noncholesterol sterols and relationship to DNA sequence polymorphism in ABCG5 and ABCG8.
###end article-title 122
###begin article-title 123
Polymorphisms in the ABCG5 and ABCG8 genes associate with cholesterol absorption and insulin sensitivity.
###end article-title 123
###begin article-title 124
Are plasma lipid levels related to ABCG5/ABCG8 polymorphisms? A preliminary study in siblings with gallstones.
###end article-title 124
###begin article-title 125
Common Variants of ABCB4 and ABCB11 and Plasma Lipid Levels: A Study in Sib Pairs with Gallstones, and Controls.
###end article-title 125
###begin article-title 126
###xml 119 127 <span type="species:ncbi:9606">patients</span>
Polymorphisms at cholesterol 7alpha-hydroxylase, apolipoproteins B and E and low density lipoprotein receptor genes in patients with gallbladder stone disease.
###end article-title 126
###begin article-title 127
Genetic evidence that apolipoprotein E4 is not a relevant susceptibility factor for cholelithiasis in two high-risk populations.
###end article-title 127
###begin article-title 128
Mutation nomenclature extensions and suggestions to describe complex mutations: a discussion.
###end article-title 128
###begin article-title 129
A note on exact tests of Hardy-Weinberg equilibrium.
###end article-title 129
###begin article-title 130
SNPassoc: an R package to perform whole genome association studies.
###end article-title 130
###begin p 131
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 131
###begin p 132
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This study was supported by the Robert Bosch Foundation (P4-1/03). Henning Wittenburg was supported by the Deutsche Forschungsgemeinschaft (WI1905 3-2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 132

